Company Cash on Hand: Ionis Pharmaceuticals (IONS)

IONS (Ionis) - company brandmark

Ionis Pharmaceuticals (IONS) relies critically on external contractors for production and testing, yet a diversified supplier network eliminates logistics disruptions. The cash liquidity metric demonstrates stabilizing cash flows, with the figure standing at 1.88. Business resilience is bolstered by investments in cutting-edge laboratories to retain leading RNA therapy research scientists.

Ionis Pharmaceuticals, Inc. - IONS Company Total Cash Amount (period 07/04/2022 - 11/21/2026)

Metric breakdowns and analytics for Ionis (IONS)

- company stock exchange capitalization indicators:
Comprehensive company analysis:IONS Ionis Pharmaceuticals
Brand item of ionispharma.com

Ionis Pharmaceuticals (IONS) holds a leading position in the high-margin RNA therapeutics segment, developing revolutionary methods to combat genetic pathologies. This metric measures the volume of liquid assets on account, determining the company's ability to generate interest income and maintain financial stability. An analysis of the enterprise's cash assets allows for an assessment of the balance between accumulating reserves and investing in the commercial development of drugs. Stable growth in liquidity confirms the issuer's long-term solvency.

Competing companies

Company Cash Volume TEM|QGEN - Company Cash Reserve|Company Cash Funds Repligen RGEN|RNA: Company Cash and Cash Equivalents|CRSP: Company Cash on Hand|GeneDx Corp (WGS) - Company Cash on Hand|RARE: Company Cash Volume|BEAM - Company Liquid Assets|SRPT (Sarepta Therapeutics) - Company Cash Volume|Company Cash on Hand Twist Bioscience Inc (TWST)|Company Cash Volume TXG|Company Liquid Assets Intellia|Stoke - Company Cash on Hand|BLFS: Company Cash and Cash Equivalents|Wave Life Sciences Corp - Company Cash Volume|Maze Therapeutics, Inc. (MAZE) - Company Cash on Hand|Sionna Therapeutics Inc (SION) - Company Cash Funds|Company Cash on Hand Prime Medicine Corp|Company Cash Funds tayshagtx.com|QURE - Company Cash Position|Company Cash on Hand MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Company Cash Position|Company Cash Volume SLDB (Solid Biosciences Inc.)|Company Cash Balance OCGN|PacBio Corp - Company Cash Volume|Benitec Biopharma Inc. (BNTC) - Company Cash on Hand|DSGN: Company Cash Volume|Company Cash and Cash Equivalents RCKT|Company Cash on Hand FDMT|Company Cash and Cash Equivalents LXEO (Lexeo Therapeutics)|Company Cash Volume KRRO|Editas Medicine, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Silence Therapeutics Inc. SLN|Company Cash Volume ProQR Therapeutics N.V. PRQR|CDXS: Company Cash on Hand|Company Cash Position Sangamo (SGMO)|NAUT (Nautilus Bio) - Company Cash on Hand|MGX - Company Liquid Assets|DTIL (Precision BioSciences Inc.) - Company Cash Volume|generationbio.com (GBIO) - Company Liquid Assets|Company Cash Funds Boundless Bio Inc (BOLD)|Company Cash Volume Exicure Inc. (XCUR)|Company Cash Funds imunon.com IMNN|Company Cash Volume Phio Pharmaceuticals PHIO|Mustang Bio Inc - Company Cash Volume|Company Cash Reserve transcodetherapeutics.com|BNGO: Company Cash Volume|Company Cash and Cash Equivalents APDN|BLUE (bluebirdbio.com) - Company Cash Volume|Company Cash Reserve ImmunoPrecise Antibodies IPA|Company Cash on Hand OMGA (omegatherapeutics.com)|Company Cash Volume Singular Genomics Systems, Inc. (OMIC)|Company Cash Volume RGLS (Regulus Therapeutics, Inc.)|Company Cash Volume Syros SYRS|Telesis Bio, Inc. - Company Cash Volume|TRACON Pharmaceuticals (TCON) - Company Cash on Hand|UBX: Company Cash Volume